The following data is part of a premarket notification filed by Roche Diagnostic Systems, Inc. with the FDA for Modification To Abuscreen Online Cocaine Metabolite.
Device ID | K983697 |
510k Number | K983697 |
Device Name: | MODIFICATION TO ABUSCREEN ONLINE COCAINE METABOLITE |
Classification | Enzyme Immunoassay, Cocaine And Cocaine Metabolites |
Applicant | ROCHE DIAGNOSTIC SYSTEMS, INC. BRANCHBURG TOWNSHIP 1080 U.S. HIGHWAY 202 Somerville, NJ 08876 -3771 |
Contact | Rita Smith |
Correspondent | Rita Smith ROCHE DIAGNOSTIC SYSTEMS, INC. BRANCHBURG TOWNSHIP 1080 U.S. HIGHWAY 202 Somerville, NJ 08876 -3771 |
Product Code | DIO |
CFR Regulation Number | 862.3250 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Special |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 1998-10-21 |
Decision Date | 1998-12-11 |
Summary: | summary |